Thoracic surgery in France
- PMID: 35928609
- PMCID: PMC9344406
- DOI: 10.21037/jtd-21-1462
Thoracic surgery in France
Abstract
Until recently, thoracic surgery in France was associated with vascular or cardiac surgery. It is now increasingly performed as a specific activity. Training of a thoracic surgeon has a common part with cardiovascular surgery during a 6-year curriculum including theory and practical practice acquired both by simulation and clinical fellowship. There are 343 board-certified surgeons performing thoracic surgery in 147 authorized centers. To be authorized to perform thoracic surgery, these centers must have at least 2 qualified surgeons and perform a minimum of 40 procedures per year for thoracic cancer. The discussion of the cases in a multidisciplinary tumor board (MDTB), validated by a written conclusion, is also mandatory and is a prerequisite for operating on patient for any cancer. All thoracic surgery procedures are recorded in a national database, Epithor. This database gives a precise idea not only of the activity but also of operative data, morbidity, mortality and follow-up. In 2023, participation to Epithor database will be a prerequisite for the certification of thoracic surgeons. Major changes in diagnostic and therapeutic options, development and innovations in video-assisted and robotically-assisted surgery, forthcoming transbronchial approaches will more likely lead to reorganize thoracic surgery with specialized and expert multidisciplinary boards as well as a concentration in high volume centers.
Keywords: Thoracic surgery; database; education.
2022 Journal of Thoracic Disease. All rights reserved.
Conflict of interest statement
Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at https://jtd.amegroups.com/article/view/10.21037/jtd-21-1462/coif). The series “Thoracic Surgery Worldwide” was commissioned by the editorial office without any funding or sponsorship. DG serves as an unpaid editorial board member of Journal of Thoracic Disease. PAT has received congress travel expenses from Europrisme, and he reports participation in advisory boards for Ethicon Endosurgery, Medtronic and AstraZeneca. He is the President of Conseil National Professionnel de Chirurgie Thoracique et Cardio-Vasculaire. The authors have no other conflicts of interest to declare.
References
Publication types
LinkOut - more resources
Full Text Sources